E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/15/2006 in the Prospect News PIPE Daily.

New Issue: NovaDel Pharma to close $14.24 million stock offering

By Sheri Kasprzak

New York, Dec. 15 - NovaDel Pharma Inc. secured $14,244,775 from a private placement of stock.

The company plans to sell 9,823,983 shares at $1.45 each.

The investors will receive warrants for 3,929,593 shares, exercisable at $1.70 each through Dec. 14, 2011.

The deal is scheduled to close Dec. 29.

Proceeds will be used for the development of the company's pipeline of oral spray drug candidates.

NovaDel, based in Flemington, N.J., develops novel drug delivery systems for prescription and over-the-counter drugs.

Issuer:NovaDel Pharma Inc.
Issue:Stock
Amount:$14,244,775
Shares:9,823,983
Price:$1.45
Warrants:For 3,929,593 shares
Warrant expiration:Dec. 14, 2011
Warrant strike price:$1.70
Announcement date:Dec. 15
Settlement date:Dec. 29
Stock symbol:Amex: NVD
Stock price:$1.52 at close Dec. 15

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.